专家论坛·乳腺癌靶向治疗
抗体偶联药物应用于乳腺癌治疗的研究进展
··············································································································· 曾 铖,张 剑
早期HR阳性/HER2阳性乳腺癌的治疗选择与思考
··························································································· 刘斌亮,谢 宁,欧阳取长
乳腺癌抗HER2单克隆抗体研究进展
··············································································································· 周涵星,徐 菲
乳腺癌靶向治疗的心脏保护
——基于《2021CSCO肿瘤治疗相关心血管毒性防治指南》解读
··············································································································· 张可欣,方凤奇